341
Views
7
CrossRef citations to date
0
Altmetric
Theme: General - Reviews

Differentiating the subtypes of social anxiety disorder

&
Pages 1271-1283 | Published online: 09 Jan 2014

References

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. American Psychiatric Association, Washington, D.C.,USA (2000).
  • Katzelnick DJ, Kobak KA, Deleire T et al. Impact of generalized social anxiety disorder in managed care. Am. J. Psychiatry 158(12), 1999–2007 (2001).
  • Wittchen HU, Fuetsch M, Sonntag H, Muller N, Liebowitz M. Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study. Eur. Psychiatry 15(1), 46–58 (2000).
  • Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62(6), 593–602 (2005).
  • Furmark T. Social phobia: overview of community surveys. Acta Psychiatr. Scand. 105(2), 84–93 (2002).
  • Beesdo K, Bittner A, Pine DS et al. Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch. Gen. Psychiatry 64(8), 903–912 (2007).
  • Vriends N, Becker ES, Meyer A, Williams SL, Lutz R, Margraf J. Recovery from social phobia in the community and its predictors: data from a longitudinal epidemiological study. J. Anxiety Disord. 21(3), 320–337 (2007).
  • Bruch MA, Fallon M, Heimberg RG. Social phobia and difficulties in occupational adjustment. J. Counsel. Psychol. 50(1), 109–117 (2003).
  • Liebowitz MR, Gorman JM, Fyer AJ, Klein DF. Social phobia. Review of a neglected anxiety disorder. Arch. Gen. Psychiatry 42(7), 729–736 (1985).
  • Wittchen HU, Stein MB, Kessler RC. Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity. Psychol. Med. 29(2), 309–323 (1999).
  • Heimberg RG, Holt CS, Schneier FR, Spitzer RL, Liebowitz MR. The issue of subtypes in the diagnosis of social phobia. J. Anxiety Disord. 312, 71–72 (1996).
  • Ost LG, Jerremalm A, Johansson J. Individual response patterns and the effects of different behavioral methods in the treatment of social phobia. Behav. Res. Ther. 19(1), 1–16 (1981).
  • Jerremalm A, Jansson L, Ost LG. Cognitive and physiological reactivity and the effects of different behavioral methods in the treatment of social phobia. Behav. Res. Ther. 24(2), 171–180 (1986).
  • Mersch PP, Emmelkamp PM, Bogels SM, Van Der Sleen J. Social phobia: individual response patterns and the effects of behavioral and cognitive interventions. Behav. Res. Ther. 27(4), 421–434 (1989).
  • Aderka IM, Nickerson A, Hofmann SG. Admixture analysis of the diagnostic subtypes of social anxiety disorder: implications for the DSM-V. J. Behav. Ther. Exp. Psychiatry 43(2), 752–757 (2012).
  • Chartrand H, Cox B, El-Gabalawy R, Clara I. Social anxiety disorder subtypes and their mental health correlates in a nationally representative Canadian sample. Can. J. Behav. Sci. 43(2), 89–98 (2011).
  • Ruscio AM, Brown TA, Chiu WT, Sareen J, Stein MB, Kessler RC. Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication. Psychol. Med. 38(1), 15–28 (2008).
  • Ha J, Lim SW, Shin YC, Oh KS. Comparison of anxiety-related traits between generalized and nongeneralized subtypes of social anxiety disorder. J. Nerv. Ment. Dis. 199(6), 390–393 (2011).
  • Dewitt DJ, Chandler-Coutts M, Offord DR et al. Gender differences in the effects of family adversity on the risk of onset of DSM-III-R social phobia. J. Anxiety Dis. 312, 71–72 (1996).
  • Heimberg RG, Hope DA, Dodge CS, Becker RE. DSM-III-R subtypes of social phobia. Comparison of generalized social phobics and public speaking phobics. J. Nerv. Ment. Dis. 178(3), 172–179 (1990).
  • Kessler RC, Stein MB, Berglund P. Social phobia subtypes in the National Comorbidity Survey. Am. J. Psychiatry 155(5), 613–619 (1998).
  • Pallanti S, Pampaloni I, Rucci P et al. Quality of life and clinical characteristics of patients with generalized and performance-focused social anxiety disorder: an Italian study. Int. J. Psychiatry Clin. Pract. 12(4), 256–260 (2008).
  • Wong N, Sarver DE, Beidel DC. Quality of life impairments among adults with social phobia: the impact of subtype. J. Anxiety Dis. 26(1), 50–57 (2012).
  • Knappe S, Beesdo-Baum K, Fehm L, Stein MB, Lieb R, Wittchen HU. Social fear and social phobia types among community youth: differential clinical features and vulnerability factors. J. Psychiatric Res. 45(1), 111–120 (2011).
  • Perugi G, Nassini S, Maremmani I et al. Putative clinical subtypes of social phobia: a factor-analytical study. Acta Psychiatr. Scand. 104(4), 280–288 (2001).
  • Levin AP, Saoud JB, Strauman T et al. Responses of ‘generalized’ and ‘discrete’ social phobics during public speaking. J. Anxiety Dis. 7(3), 207–221 (1993).
  • Beidel DC, Rao PA, Scharfstein L, Wong N, Alfano CA. Social skills and social phobia: an investigation of DSM-IV subtypes. Behav. Res. Ther. 48(10), 992–1001 (2010).
  • Mcteague LM, Lang PJ, Laplante MC, Cuthbert BN, Strauss CC, Bradley MM. Fearful imagery in social phobia: generalization, comorbidity, and physiological reactivity. Biol. Psychiatry 65(5), 374–382 (2009).
  • Mcteague LM, Lang PJ. The anxiety spectrum and the reflex physiology of defense: from circumscribed fear to broad distress. Depress. Anxiety 29(4), 264–281 (2012).
  • Blanco C, Bragdon LB, Schneier FR, Liebowitz MR. The evidence-based pharmacotherapy of social anxiety disorder. Int. J. Neuropsychopharmacol. 16(1), 235–249 (2013).
  • Blanco C, Schneier FR, Schmidt A et al. Pharmacological treatment of social anxiety disorder: a meta-analysis. Depress. Anxiety 18(1), 29–40 (2003).
  • Gould RA, Buckminster S, Pollack MH, Otto MW, Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: a meta-analysis. Clin. Psychol. Sci. Pract. 312, 71–72 (1996).
  • Van Der Linden GJ, Stein DJ, Van Balkom AJ. The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials. Int. Clin. Psychopharmacol. 15(Suppl. 2), S15–S23 (2000).
  • Dalrymple KL. Issues and controversies surrounding the diagnosis and treatment of social anxiety disorder. Expert Rev. Neurother. 12(8), 993–1008; quiz 1009 (2012).
  • Lader M. Benzodiazepines revisited–will we ever learn? Addiction 106(12), 2086–2109 (2011).
  • Versiani M, Amrein R, Montgomery SA. Social phobia: long-term treatment outcome and prediction of response–a moclobemide study. Int. Clin. Psychopharmacol. 12(5), 239–254 (1997).
  • Rodebaugh TL, Holaway RM, Heimberg RG. The treatment of social anxiety disorder. Clin. Psychol. Rev. 24(7), 883–908 (2004).
  • Stein DJ, Cameron A, Amrein R, Montgomery SA. Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. Int. Clin. Psychopharmacol. 17(4), 161–170 (2002).
  • Heimberg RG, Liebowitz MR, Hope DA et al. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch. Gen. Psychiatry 55(12), 1133–1141 (1998).
  • Liebowitz MR, Schneier F, Campeas R et al. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Arch. Gen. Psychiatry 49(4), 290–300 (1992).
  • Stein DJ, Stein MB, Goodwin W, Kumar R, Hunter B. The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacology 158(3), 267–272 (2001).
  • Turner SM, Beidel DC, Jacob RG. Social phobia: a comparison of behavior therapy and atenolol. J. consult. Clin. Psychol. 62(2), 350–358 (1994).
  • Ponniah K, Hollon SD. Empirically supported psychological interventions for social phobia in adults: a qualitative review of randomized controlled trials. Psychol. Med. 38(1), 3–14 (2008).
  • Zaider TI, Heimberg RG. Non-pharmacologic treatments for social anxiety disorder. Acta Psychiatr. Scand. Suppl. (417), 72–84 (2003).
  • Hope DA, Herbert JD, White C. Diagnostic subtype, avoidant personality disorder, and efficacy of cognitive-behavioral group therapy for social phobia. Cog. Ther. Res. 19(4), 399–417 (1995).
  • Brown EJ, Heimberg RG, Juster HR. Social phobia subtype and avoidant personality disorder: effect on severity of social phobia, impairment, and outcome of cognitive behavioral treatment. Behav. Ther. 312, 71–72 (1996).
  • Ruiperez MA, Garcia-Palacios A, Botella C. Clinical features and treatment response in social phobia: axis II comorbidity and social phobia subtypes. Psichothema 14(2), 426–433 (2002).
  • Levin JB, Hermesh H, Marom S. Social phobia subtyping with the MMPI-2. J. Clin. Psychol. 57(12), 1489–1502 (2001).
  • Watanabe N, Furukawa TA, Chen J et al. Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study. BMC Psychiatry 10, 81 (2010).
  • Bogels SM, Alden L, Beidel DC et al. Social anxiety disorder: questions and answers for the DSM-V. Depress. Anxiety 27(2), 168–189 (2010).
  • Liebowitz MR. Social phobia. Mod. Probl. Pharmacopsychiatry 312, 71–72 (1996).
  • Rytwinsky NK, Fresco DM, Heimberg RG, Al. E. Screening for social anxiety disorder within the self-report version of the Liebowitz Social Anxiety Scale. Depress. Anxiety 312, 71–72 (1996).
  • Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J. Anxiety Dis. 16(6), 661–673 (2002).
  • Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav. Res. Ther. 36(4), 455–470 (1998).
  • Hart TA, Jack MS, Turk CL, Heimberg RG. Issues for the measurement of social phobia. In: Social Phobia: Recent Trends and Progress. Westenberg HGM, Den Boer JA (Eds). Syn-Thesis Publishers, Amsterdam, Netherlands, 133–155 (1999).
  • Turner SM, Beidel DC, Dancu CV, Stanley MA. An empirically derived inventory to measure social fears and social anxiety: the Social Phobia and Anxiety Inventory. Psychol. Assess. 1(1), 35–40 (1989).
  • Ries BJ, Mcneil DW, Boone ML, Turk CL, Carter LE, Heimberg RG. Assessment of contemporary social phobia verbal report instruments. Behav. Res. Ther. 36(10), 983–994 (1998).
  • Brown EJ, Turovsky J, Heimberg RG, Juster HR, Brown TA, Barlow DH. Validation of the Social Interaction Anxiety Scale and the Social Phobia Scale across the anxiety disorders. Psychol. Assess. 9(1), 21–27 (1997).
  • Heimberg RG, Mueller G, Holt C, Hope D, Liebowitz M. Assessment of anxiety in social interaction and being observed by others: the Social Interaction Anxiety Scale and the Social Phobia Scale. Behav. Ther. 23(1), 53–73 (1992).
  • El-Gabalawy R, Cox B, Clara I, Mackenzie C. Assessing the validity of social anxiety disorder subtypes using a nationally representative sample. J. Anxiety Dis. 24(2), 244–249 (2010).
  • Acaturk C, De Graaf R, Van Straten A, Ten Have M, Cuijpers P. Social phobia and number of social fears, and their association with comorbidity, health-related quality of life and help-seeking: a population-based study. Soc. Psychiatry Psychiatr. Epidemiol. 312, 71–72 (1996).
  • Stein DJ, Ruscio AM, Lee S et al. Subtyping social anxiety disorder in developed and developing countries. Depress. Anxiety 27(4), 390–403 (2010).
  • Filho AS, Hetem LA, Ferrari MC et al. Social anxiety disorder: what are we losing with the current diagnostic criteria? Acta Psychiatr. Scand. 121(3), 216–226 (2010).
  • Chambless DL, Fydrich T, Rodebaugh TL. Generalized social phobia and avoidant personality disorder: meaningful distinction or useless duplication? Depress. Anxiety 25(1), 8–19 (2008).
  • Hook JN, Valentiner DP. Are specific and generalized social phobias qualitatively distinct? Clin. Psychol. 9(4), 379–395 (2002).
  • Cox BJ, Clara IP, Sareen J, Stein MB. The structure of feared social situations among individuals with a lifetime diagnosis of social anxiety disorder in two independent nationally representative mental health surveys. Behav. Res. Ther. 46(4), 477–486 (2008).
  • Green JG, Avenevoli S, Finkelman M et al. Validation of the diagnoses of panic disorder and phobic disorders in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement. Int. J. Methods Psychiatric Res. 20(2), 105–115 (2011).
  • Blote AW, Kint MJW, Miers AC, Westenberg M. The relation between public speaking anxiety and social anxiety: a review. J. Anxiety Dis. 312, 71–72 (1996).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edition). American Psychiatric Association, Arlington, VA, USA (2013).
  • Davidson JRT. Pharmacotherapy of social phobia. Acta Psychiatrica Scand. 108(Suppl. 417), 65–71 (2003).
  • Hofmann SG. Treatment of Social Phobia: Potential Mediators and Moderators. Clin. Psychol. 7(1), 3–16 (2000).
  • Takahashi T.Social phobia syndrome in Japan. Compr. Psychiatry 30(1), 45–52 (1989).
  • Lochner C, Stein DJ. Olfactory reference syndrome: diagnostic criteria and differential diagnosis. J. Postgrad. Med. 49(4), 328–331 (2003).
  • Hofmann SG, Anu Asnaani MA, Hinton DE. Cultural aspects in social anxiety and social anxiety disorder. Depress. Anxiety 27(12), 1117–1127 (2010).
  • Nagata T, Van Vliet I, Yamada H, Kataoka K, Iketani T, Kiriike N. An open trial of paroxetine for the “offensive subtype” of taijin kyofusho and social anxiety disorder. Depress. Anxiety 23(3), 168–174 (2006).
  • Stein D. Social anxiety disorder in the West and in the East.Annu. Clin. Psychiatry 312, 71–72 (1996).
  • Feusner JD, Phillips KA, Stein DJ. Olfactory reference syndrome: issues for DSM-V. Depress. Anxiety 27(6), 592–599 (2010).
  • Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 46(4), 317–325 (2005).
  • Kachin KE, Newman MG, Pincus AL. An interpersonal problem approach to the division of social phobia subtypes. Behavior. Ther. 312, 71–72 (1996).
  • Cain NM, Pincus AL, Grosse Holtforth M. Interpersonal subtypes in social phobia: diagnostic and treatment implications. J. Pers. Assess. 92(6), 514–527 (2010).
  • Calamaras MR, Tone EB, Anderson PL. A pilot study of attention bias subtypes: examining their relation to cognitive bias and their change following cognitive behavioral therapy. J. Clin. Psychol. 68(7), 745–754 (2012).
  • Price M, Tone EB, Anderson PL. Vigilant and avoidant attention biases as predictors of response to cognitive behavioral therapy for social phobia. Depress. Anxiety 312, 71–72 (1996).
  • Carleton RN, Collimore KC, Asmundson GJ. “It’s not just the judgements–It’s that I don’t know”: intolerance of uncertainty as a predictor of social anxiety. J. Anxiety Dis. 24(2), 189–195 (2010).
  • Riskind JH, Tzur D, Williams NL, Mann B, Shahar G. Short-term predictive effects of the looming cognitive style on anxiety disorder symptoms under restrictive methodological conditions. Behav. Res. Ther. 45(8), 1765–1777 (2007).
  • Mcevoy PM, Mahoney AE. To be sure, to be sure: intolerance of uncertainty mediates symptoms of various anxiety disorders and depression. Behav. Ther. 43(3), 533–545 (2012).
  • Voncken MJ, Bogels SM. Physiological blushing in social anxiety disorder patients with and without blushing complaints: two subtypes? Biol. Psychol. 81(2), 86–94 (2009).
  • Gerlach AL, Wilhelm FH, Gruber K, Roth WT. Blushing and physiological arousability in social phobia. J. abnorm. Psychol. 110(2), 247–258 (2001).
  • Weeks JW, Heimberg RG, Rodebaugh TL, Norton PJ. Exploring the relationship between fear of positive evaluation and social anxiety. J. Anxiety Dis. 22(3), 386–400 (2008).
  • Dalrymple KL, Zimmerman M. Treatment-seeking for social anxiety disorder in a general outpatient psychiatry setting. Psychiatry Res. 187(3), 375–381 (2011).
  • Grant BF, Hasin DS, Blanco C et al. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 66(11), 1351–1361 (2005).
  • Hamm AO. Specific phobias. Psychiatr. Clin. North Am 32(3), 577–591 (2009).
  • Kazdin AE. Treatment outcomes, common factors, and continued neglect of mechanisms of change. Clin. Psychol. 12, 184–188. (2005).
  • Dalrymple KL, Herbert JD. Acceptance and commitment therapy for generalized social anxiety disorder: a pilot study. Behav. Modif. 31(5), 543–568 (2007).
  • Kocovski NL, Fleming JE, Rector NA. Mindfulness and acceptance-based group therapy for social anxiety disorder: An open trial. Cogn. Behav. Pract. 16(3), 276–289 (2009).
  • Lipsitz JD, Gur M, Vermes D et al. A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depress. Anxiety 25(6), 542–553 (2008).
  • Stangier U, Schramm E, Heidenreich T, Berger M, Clark DM. Cognitive therapy vs interpersonal psychotherapy in social anxiety disorder: a randomized controlled trial. Arch. Gen. Psychiatry 68(7), 692–700 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.